tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market
Advertisement

Valerio Therapeutics (ALVIO) Financial Statements

Compare
0 Followers

Valerio Therapeutics Financial Overview

Valerio Therapeutics's market cap is currently €21.12M. The company's EPS TTM is €; its P/E ratio is ―; Valerio Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 1.79M€ 1.80M€ 1.44M€ 4.06M€ 1.78M
Gross Profit€ 1.28M€ 1.27M€ 929.00K€ 3.69M€ -166.00K
Operating Income€ -16.49M€ -20.29M€ -17.11M€ -5.58M€ -7.81M
EBITDA€ -12.06M€ -18.44M€ -17.04M€ -4.90M€ 2.33M
Net Income€ -23.93M€ -20.34M€ -19.56M€ -5.94M€ 1.09M
Balance Sheet
Cash & Short-Term Investments€ 1.18M€ 6.82M€ 14.59M€ 17.89M€ 14.52M
Total Assets€ 17.93M€ 35.27M€ 43.09M€ 53.06M€ 46.51M
Total Debt€ 13.44M€ 9.00M€ 10.09M€ 14.76M€ 6.26M
Net Debt€ 12.26M€ 2.18M€ -4.50M€ -3.12M€ -8.27M
Total Liabilities€ 26.19M€ 20.47M€ 20.82M€ 20.12M€ 17.47M
Stockholders' Equity€ -8.93M€ 14.80M€ 22.27M€ 32.94M€ 29.04M
Cash Flow
Free Cash Flow€ -12.78M€ -18.78M€ -9.93M€ -8.71M€ -4.80M
Operating Cash Flow€ -12.46M€ -18.60M€ -9.44M€ -8.57M€ -4.68M
Investing Cash Flow€ -1.39M€ -177.00K€ -409.00K€ -66.00K€ 6.01M
Financing Cash Flow€ 4.21M€ 10.76M€ 6.46M€ 11.98M€ 7.48M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History

Valerio Therapeutics Debt to Assets

Valerio Therapeutics Cash Flow

Valerio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis